Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CheRe CunJin Gao for primary Sjögren's syndrome
ChiCTR2300078780Phase 2Not yet recruiting
- Sponsor
- Chongqing Traditional Chinese Medicine Hospital
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Chere Cunjin Gao in primary Sjögren's syndrome (2 arms), sponsored by Chongqing Traditional Chinese Medicine Hospital. Primary endpoints: European Alliance of Associations for Rheumatology Sjögren's Syndrome Patient Reported Index, Schirmer's test and 2 more. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
Chere Cunjin Gao
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on ChiCTR2300078780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078780.